1074 related articles for article (PubMed ID: 31842773)
1. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.
Agizew T; Boyd R; Mathebula U; Mathoma A; Basotli J; Serumola C; Pals S; Finlay A; Lekone P; Rankgoane-Pono G; Tlhakanelo T; Chihota V; Auld AF
PLoS One; 2020; 15(6):e0234646. PubMed ID: 32530972
[TBL] [Abstract][Full Text] [Related]
3. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
[TBL] [Abstract][Full Text] [Related]
4. Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality.
Auld AF; Agizew T; Pals S; Finlay A; Ndwapi N; Boyd R; Alexander H; Mathoma A; Basotli J; Gwebe-Nyirenda S; Shepherd J; Ellerbrock TV; Date A
BMC Infect Dis; 2016 Oct; 16(1):606. PubMed ID: 27782821
[TBL] [Abstract][Full Text] [Related]
5. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.
Cox HS; Mbhele S; Mohess N; Whitelaw A; Muller O; Zemanay W; Little F; Azevedo V; Simpson J; Boehme CC; Nicol MP
PLoS Med; 2014 Nov; 11(11):e1001760. PubMed ID: 25423041
[TBL] [Abstract][Full Text] [Related]
6. Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.
Di Tanna GL; Khaki AR; Theron G; McCarthy K; Cox H; Mupfumi L; Trajman A; Zijenah LS; Mason P; Bandason T; Durovni B; Bara W; Hoelscher M; Clowes P; Mangu C; Chanda D; Pym A; Mwaba P; Cobelens F; Nicol MP; Dheda K; Churchyard G; Fielding K; Metcalfe JZ
Lancet Glob Health; 2019 Feb; 7(2):e191-e199. PubMed ID: 30683238
[TBL] [Abstract][Full Text] [Related]
7. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.
Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F
PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549
[TBL] [Abstract][Full Text] [Related]
8. Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial.
Auld AF; Agizew T; Mathoma A; Boyd R; Date A; Pals SL; Serumola C; Mathebula U; Alexander H; Ellerbrock TV; Rankgoane-Pono G; Pono P; Shepherd JC; Fielding K; Grant AD; Finlay A
BMC Med; 2020 Feb; 18(1):19. PubMed ID: 32041583
[TBL] [Abstract][Full Text] [Related]
9. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study.
Akanbi MO; Achenbach C; Taiwo B; Idoko J; Ani A; Isa Y; Agbaji O; Ukoli C; Akande P; Maiga M; Murphy RL
BMC Pulm Med; 2017 May; 17(1):87. PubMed ID: 28558662
[TBL] [Abstract][Full Text] [Related]
11. The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear.
Zimba O; Tamuhla T; Basotli J; Letsibogo G; Pals S; Mathebula U; Mathoma A; Serumola C; Ramogale K; Boyd R; Tran T; Finlay A; Auld A; Date A; Alexander H; Chihota V; Agizew T
Pan Afr Med J; 2019; 33():110. PubMed ID: 31489088
[TBL] [Abstract][Full Text] [Related]
12. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
[TBL] [Abstract][Full Text] [Related]
13. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.
Walusimbi S; Semitala F; Bwanga F; Haile M; De Costa A; Davis L; Joloba M; Hoffner S; Kamya M
Pan Afr Med J; 2016; 23():154. PubMed ID: 27303572
[TBL] [Abstract][Full Text] [Related]
15. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
[TBL] [Abstract][Full Text] [Related]
16. Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial.
Trajman A; Durovni B; Saraceni V; Menezes A; Cordeiro-Santos M; Cobelens F; Van den Hof S
PLoS One; 2015; 10(4):e0123252. PubMed ID: 25915745
[TBL] [Abstract][Full Text] [Related]
17. The New Xpert MTB/RIF Ultra: Improving Detection of
Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
[TBL] [Abstract][Full Text] [Related]
18. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
[TBL] [Abstract][Full Text] [Related]
19. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
Rachow A; Zumla A; Heinrich N; Rojas-Ponce G; Mtafya B; Reither K; Ntinginya EN; O'Grady J; Huggett J; Dheda K; Boehme C; Perkins M; Saathoff E; Hoelscher M
PLoS One; 2011; 6(6):e20458. PubMed ID: 21738575
[TBL] [Abstract][Full Text] [Related]
20. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.
Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S
J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
